Taylor Swift, Tim McGraw to Perform at Stand Up to Cancer Telethon

Written by SLN Staff Writer
Taylor Swift, Tim McGraw to Perform at Stand Up to Cancer Telethon

Taylor Swift and Tim McGraw will Stand Up To Cancer on September 7 with performances on the third annual Stand Up To Cancer (SU2C) telethon. The country superstars are part of an A-list line-up that includes Gwyneth Paltrow, Julia Roberts, Matt Damon, Michael Douglas, Jessica Biel, Samuel L. Jackson, Jeremy Renner, Seth Rogen, Emma Stone, Coldplay, Alicia Keys, and SU2C Co-Founder Katie Couric.

Actors and personalities including Simon Baker, Jordana Brewster, Diem Brown, Dana Delany, Chelsea Handler, Marg Helgenberger, Rashida Jones, Minka Kelly, Joe Manganiello, Jillian Michaels, Masi Oka, Ana Maria Polo, and Alison Sweeney have also been confirmed to participate in the broadcast. Additional stars and performers will be announced in the coming weeks.

This star-studded appeal continues to help build public support for groundbreaking translational research accelerating the delivery of new therapies to patients, getting them from the “bench to the bedside” as quickly as possible. SU2C brings together scientists from different disciplines across various institutions to collaborate.

Stand Up To Cancer will air Friday, Sept. 7 (8:00-9:00 PM ET /PT). ABC, CBS, FOX and NBC will donate one hour of simultaneous commercial-free primetime for the nationally televised fundraising special on Friday, Sept. 7, to be broadcast live from the Shrine Auditorium in Los Angeles. BIO, E!, ENCORE, HBO, HBO Latino, ION Television, LMN (Lifetime Movie Network), Logo, MLB Network, mun2, Palladia, SHOWTIME, Smithsonian Channel, STARZ, STYLE, TBS and VH1 have also committed to carry the Stand Up To Cancer telecast. The program will include a celebrity phone/multi-media bank that will allow viewers to interact with participating talent. Viewers will also be able to donate via text-to-give and at standup2cancer.org. One hundred percent of all public donations will go directly to cancer research.